242 related articles for article (PubMed ID: 10364284)
1. Effects of soluble CD4 on simian immunodeficiency virus infection of CD4-positive and CD4-negative cells.
Schenten D; Marcon L; Karlsson GB; Parolin C; Kodama T; Gerard N; Sodroski J
J Virol; 1999 Jul; 73(7):5373-80. PubMed ID: 10364284
[TBL] [Abstract][Full Text] [Related]
2. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
[TBL] [Abstract][Full Text] [Related]
3. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding.
Sattentau QJ; Moore JP; Vignaux F; Traincard F; Poignard P
J Virol; 1993 Dec; 67(12):7383-93. PubMed ID: 7693970
[TBL] [Abstract][Full Text] [Related]
4. Lineage-Specific Differences between the gp120 Inner Domain Layer 3 of Human Immunodeficiency Virus and That of Simian Immunodeficiency Virus.
Ding S; Medjahed H; Prévost J; Coutu M; Xiang SH; Finzi A
J Virol; 2016 Nov; 90(22):10065-10073. PubMed ID: 27535053
[TBL] [Abstract][Full Text] [Related]
5. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography.
White TA; Bartesaghi A; Borgnia MJ; de la Cruz MJ; Nandwani R; Hoxie JA; Bess JW; Lifson JD; Milne JL; Subramaniam S
J Virol; 2011 Dec; 85(23):12114-23. PubMed ID: 21937655
[TBL] [Abstract][Full Text] [Related]
7. A single amino acid change and truncated TM are sufficient for simian immunodeficiency virus to enter cells using CCR5 in a CD4-independent pathway.
Bonavia A; Bullock BT; Gisselman KM; Margulies BJ; Clements JE
Virology; 2005 Oct; 341(1):12-23. PubMed ID: 16061266
[TBL] [Abstract][Full Text] [Related]
8. CD4-independent binding of SIV gp120 to rhesus CCR5.
Martin KA; Wyatt R; Farzan M; Choe H; Marcon L; Desjardins E; Robinson J; Sodroski J; Gerard C; Gerard NP
Science; 1997 Nov; 278(5342):1470-3. PubMed ID: 9367961
[TBL] [Abstract][Full Text] [Related]
9. Multiple antiviral activities of cyanovirin-N: blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses.
Dey B; Lerner DL; Lusso P; Boyd MR; Elder JH; Berger EA
J Virol; 2000 May; 74(10):4562-9. PubMed ID: 10775592
[TBL] [Abstract][Full Text] [Related]
10. CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.
Wetzel KS; Yi Y; Elliott STC; Romero D; Jacquelin B; Hahn BH; Muller-Trutwin M; Apetrei C; Pandrea I; Collman RG
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903799
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD4 and CD4-mimetic compounds inhibit HIV-1 infection by induction of a short-lived activated state.
Haim H; Si Z; Madani N; Wang L; Courter JR; Princiotto A; Kassa A; DeGrace M; McGee-Estrada K; Mefford M; Gabuzda D; Smith AB; Sodroski J
PLoS Pathog; 2009 Apr; 5(4):e1000360. PubMed ID: 19343205
[TBL] [Abstract][Full Text] [Related]
12. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
[TBL] [Abstract][Full Text] [Related]
13. Amino acid 324 in the simian immunodeficiency virus SIVmac V3 loop can confer CD4 independence and modulate the interaction with CCR5 and alternative coreceptors.
Pöhlmann S; Davis C; Meister S; Leslie GJ; Otto C; Reeves JD; Puffer BA; Papkalla A; Krumbiegel M; Marzi A; Lorenz S; Münch J; Doms RW; Kirchhoff F
J Virol; 2004 Apr; 78(7):3223-32. PubMed ID: 15016843
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of soluble CD4 binding to cells expressing human immunodeficiency virus type 1 envelope glycoprotein.
Dimitrov DS; Hillman K; Manischewitz J; Blumenthal R; Golding H
J Virol; 1992 Jan; 66(1):132-8. PubMed ID: 1727475
[TBL] [Abstract][Full Text] [Related]
15. CD4-independent, CCR5-dependent infection of brain capillary endothelial cells by a neurovirulent simian immunodeficiency virus strain.
Edinger AL; Mankowski JL; Doranz BJ; Margulies BJ; Lee B; Rucker J; Sharron M; Hoffman TL; Berson JF; Zink MC; Hirsch VM; Clements JE; Doms RW
Proc Natl Acad Sci U S A; 1997 Dec; 94(26):14742-7. PubMed ID: 9405683
[TBL] [Abstract][Full Text] [Related]
16. Loss of a conserved N-linked glycosylation site in the simian immunodeficiency virus envelope glycoprotein V2 region enhances macrophage tropism by increasing CD4-independent cell-to-cell transmission.
Yen PJ; Herschhorn A; Haim H; Salas I; Gu C; Sodroski J; Gabuzda D
J Virol; 2014 May; 88(9):5014-28. PubMed ID: 24554659
[TBL] [Abstract][Full Text] [Related]
17. Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates.
Moore JP; McKeating JA; Huang YX; Ashkenazi A; Ho DD
J Virol; 1992 Jan; 66(1):235-43. PubMed ID: 1727487
[TBL] [Abstract][Full Text] [Related]
18. Characterization and epitope mapping of neutralizing monoclonal antibodies produced by immunization with oligomeric simian immunodeficiency virus envelope protein.
Edinger AL; Ahuja M; Sung T; Baxter KC; Haggarty B; Doms RW; Hoxie JA
J Virol; 2000 Sep; 74(17):7922-35. PubMed ID: 10933700
[TBL] [Abstract][Full Text] [Related]
19. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus.
Chertova E; Bess JW; Crise BJ; Sowder II RC; Schaden TM; Hilburn JM; Hoxie JA; Benveniste RE; Lifson JD; Henderson LE; Arthur LO
J Virol; 2002 Jun; 76(11):5315-25. PubMed ID: 11991960
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.
Berger EA; Lifson JD; Eiden LE
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8082-6. PubMed ID: 1896455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
